Login to Your Account



Somaxon Secures Partner P&G to Co-Promote Insomnia Drug

By Catherine Hollingsworth


Thursday, August 26, 2010
San Diego-based Somaxon Pharmaceuticals Inc. plans to launch its Silenor insomnia drug in September with the help of Proctor & Gamble Co., which will co-promote the prescription drug in the U.S. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription